Connect with us
DAPA Banner

Business

The Dip Before The Re-Rate, Xiaomi's Window Of Maximum Pessimism

Published

on

The Dip Before The Re-Rate, Xiaomi's Window Of Maximum Pessimism
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Napco Q3: Fair-Value Entry Point Before A Potential 2027 Inflection (Rating Upgrade)

Published

on

Napco Q3: Fair-Value Entry Point Before A Potential 2027 Inflection (Rating Upgrade)

Napco Q3: Fair-Value Entry Point Before A Potential 2027 Inflection (Rating Upgrade)

Continue Reading

Business

Softer club channel sales hinder The Marzetti Co.

Published

on

Softer club channel sales hinder The Marzetti Co.

Frozen bread a bright spot in quarter.

Continue Reading

Business

SoundHound launches self-learning AI agent platform OASYS

Published

on


SoundHound launches self-learning AI agent platform OASYS

Continue Reading

Business

Duolingo Stock Falls Deeper. What Earnings Say About User Growth.

Published

on

Duolingo Stock Falls Deeper. What Earnings Say About User Growth.

Duolingo Stock Falls Deeper. What Earnings Say About User Growth.

Continue Reading

Business

Pfizer (PFE) earnings Q1 2026

Published

on

Pfizer (PFE) earnings Q1 2026

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City.

View Press | Corbis News | Getty Images

Pfizer on Tuesday posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as its recently launched and acquired products showed growth.

Advertisement

Older top-selling drugs, including its blood thinner Eliquis, also helped drive demand in the quarter and offset the decline in revenue from Pfizer’s Covid vaccine and antiviral pill to treat the virus, Paxlovid.

Here’s what the company reported for the first quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: 

  • Earnings per share: 75 cents adjusted vs. 72 cents expected
  • Revenue: $14.45 billion vs. $13.79 billion expected

The pharmaceutical giant is looking to longer-term investments in its pipeline, including its recent $10 billion acquisition of the obesity biotech Metsera, to counter waning Covid product sales and declines from older drugs. Pfizer is focused on several crucial data releases this year, including late-stage trial results on an experimental targeted drug in lung cancer. 

Pfizer reported revenue of $14.45 billion for the first quarter, up 5% from the same period a year ago. Sales increases for key products helped to counteract struggles in its Covid business.

The company booked net income of $2.69 billion, or 47 cents per share. That compares with net income of $2.97 billion, or 52 cents per share, during the same period a year ago.

Advertisement

Excluding certain items, including restructuring charges and costs associated with intangible assets, Pfizer posted earnings per share of 75 cents for the quarter.

Pfizer reaffirmed its 2026 outlook, expecting full-year adjusted profit to come in between $2.80 and $3 per share, and revenue to total $59.5 billion to $62.5 billion. That sales range would be roughly flat or down slightly compared with 2025 revenue of $62.6 billion.

Pfizer previously said the lackluster revenue outlook comes in part from declining sales of its Covid vaccine and Paxlovid, which it expects to fall by about $1.5 billion year over year to $5 billion. 

The company also pointed to another roughly $1.5 billion year-over-year expected drop in sales due to certain products losing their market exclusivity. Some blockbuster drugs, such as the company’s pneumonia vaccine Prevnar, are facing more competition from rivals.

Advertisement

The results come a week after Pfizer entered into settlement agreements with three generic drug manufacturers that effectively extend the company’s U.S. patent protection for Vyndamax until June 1, 2031. That’s a prescription medicine that helps treat a rare, serious heart condition.

Newer and older products offset Covid decline

Sales of Pfizer’s Covid shot and Paxlovid both came in well under analysts’ estimates, according to StreetAccount.

The vaccine raked in $232 million in revenue for the quarter, down 59% from the same period a year ago, while Paxlovid sales fell 62% to $186 million. Analysts were expecting sales of $445.9 million and $286.2 million, respectively, for the two products.

Meanwhile, Eliquis generated $2.17 billion in sales for the quarter, up 13% from the year-ago period. Analysts expected $1.96 billion in revenue, according to StreetAccount estimates. 

Advertisement

Other older drugs and some newer products also beat estimates for the quarter. 

Targeted cancer drug Padcev booked $591 million in revenue, up 39% from the same period a year ago and surpassing the $542.3 million that analysts were expecting. 

Pfizer’s vaccine against respiratory syncytial virus, a more recently launched product, booked $180 million in sales for the first quarter. That’s up 37% from the year-earlier period and comes in higher than the $145.1 million that analysts were expecting. 

Sales of recently launched and acquired products grew 22% operationally during the quarter, Pfizer said.

Advertisement
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Great Elm Capital Corporation 2026 Q1 – Results – Earnings Call Presentation (NASDAQ:GECC) 2026-05-05

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q1: 2026-05-04 Earnings Summary

EPS of $0.36 beats by $0.12

 | Revenue of $9.54M (-23.62% Y/Y) misses by $941.00K

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Advertisement
Continue Reading

Business

Regeneration specialist ION acquired by VINCI Construction UK

Published

on

Business Live

Merged business working on projects in Derby, Birkenhead and Wakefield

The UK division of VINCI Construction has acquired ION Property Group, which is working on major urban regeneration schemes including this one in Derby city centre

The UK division of VINCI Construction has acquired ION Property Group. The businesses are already working on major urban regeneration schemes including the Market Place n Derby city centre(Image: ION Developments)

Liverpool developer ION Property Group has been acquired by VINCI Construction to create an expanded business that bosses say “has ambitions for significant future growth”.

The UK division of VINCI Construction plans to merge ION with VINCI UK Developments to create a business “focused on the local authority urban regeneration market”. The merged business will keep the ION Developments brand and will be headquartered at the Port of Liverpool Building.

VINCI and ION are already working together on major urban regeneration schemes including the Market Place scheme in Derby city centre, Chester Northgate 2, the Coventry Civic Centre site and Northwich Weaver Square.

Meanwhile ION’s existing development portfolio including Borough Yard, Birkenhead, Stafford town centre and Westgate Wakefield will be delivered by the newly combined group . ION had been privately owned and operated for 36 years.

Advertisement

The merged business will be led by managing director Steve Parry and commercial director Rob Mason – both former ION directors – alongside finance director Ian Hudson, who led the finance team at VINCI UK Developments.

The VINCI deal will see the departure of shareholders and non-executive directors Peter Hynd and Gavin Douglas.

Steve Parry said: “At a time when local authorities and other public bodies across the UK are exploring new solutions for urban regeneration and the use of their land assets, this is the ideal moment to bring together these two specialist businesses to create a single regeneration developer which has the vision, experience and resources to bring projects of all sizes to life. We already have a strong forward pipeline and the new structure will only enhance our capacity to deliver these and other future projects.”

Peter Hynd said: “ION has delivered many transformational regeneration schemes that have had a positive impact on our towns, cities and communities by delivering high quality urban buildings that have created a sense of place. Many of these projects were regarded as ‘too difficult’, but we have delivered consistently, working closely with our public sector partners.

Advertisement

“This deal with VINCI stands as testament to our legacy of success and we are proud to be leaving the business in such a strong position, with an incredibly bright future ahead and we wish the hard-working ION team every success in the future.”

Scott Wardrop, chief executive of VINCI Construction in the UK, said: “We are delighted to confirm this agreement, which will see the creation of a consolidated development business, that can harness even more of our collective strengths and support greater numbers of local authorities and other clients to make a long-lasting, positive change to their communities across future generations.”

To find all the planning applications, traffic diversions, road layout changes, alcohol licence applications and more in your community, visit the Public Notices Portal.

Advertisement
Continue Reading

Business

Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.75%

Published

on


Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.75%

Continue Reading

Business

Cornerstone University launches $24K accredited degree via smartphone

Published

on

Cornerstone University launches $24K accredited degree via smartphone

Americans looking to earn degrees at their own speed can now do so via their mobile phones after Cornerstone University tailored degree offerings in its business program to cater to students who prefer a self-paced program that can be completed on a smartphone.

“We developed the nation’s first mobile platform to deliver an accredited undergraduate degree and a master’s degree as well, all via your mobile phone,” Cornerstone University President Gerson Moreno-Riaño told FOX Business in an interview.

Advertisement

Moreno-Riaño said that the program launched in August and has about 250 students enrolled. Students in what’s known as the SOAR program can obtain an associate’s or bachelor’s degree in strategic business management, or a master’s degree in organizational leadership.

“One of the beautiful things we’ve seen is that the persistence rate from month-to-month is 91%, so students are sticking with this and completing it,” he said, adding that some students who transferred in with prior credits to complete a degree will be the program’s first graduates this year.

ROWE WARNS OF MASSIVE WORKFORCE SHAKEUP, SAYS SANDERS IS RIGHT: ‘REVOLUTION UNLIKE ANYTHING’ WE’VE SEEN COMING

Man emails on phone

The SOAR program allows students to engage with learning materials in small portions on their smartphones. (iStock)

Moreno-Riaño said that Cornerstone’s price point for its SOAR bachelor’s degree is $24,000 from start to finish, while the master’s degree is $12,000.

Advertisement

“More than half of our current students enrolled in the program now are paying no tuition due to scholarships and grants.”

“We see this as an opportunity to address a gap in our country now when it comes to education, and frankly, we’re convinced that the current American higher ed infrastructure cannot address this challenge. It was built for what I call traditional brick and mortar students,” he said.

“We thought, how can we take this ubiquitous piece of technology that everybody has, that everyone spends a lot of time on? On average, in our country, we’re talking about well over four hours a day that adults are on their mobile devices.”

FEDERAL COURT TERMINATES BIDEN-ERA STUDENT LOAN PLAN AFFECTING MILLIONS NATIONWIDE

Advertisement
A college class in a lecture hall

Cornerstone University’s SOAR degree program allows students to earn degrees on their mobile phones outside a traditional classroom. (iStock)

Moreno-Riaño said Cornerstone tested the app for over a year with about 120 students, which informed the university’s process of revising and launching the SOAR app.

He said that Cornerstone is deeply concerned with how it reaches out to non-traditional students and disenchanted students, some of whom haven’t tried to pursue a degree while others tried a traditional college experience and aren’t willing to return.

Moreno-Riaño said that when Cornerstone was mapping out the program, it understood that the traditional curriculum of 120 credit hours in a degree program couldn’t be mapped over to a mobile app, so the school sought to unpackage those courses into “bite-sized chunks of educational content.”

RECENT COLLEGE GRADS ARE LOSING THEIR EDGE IN THE JOB MARKET, STUDY SHOWS

Advertisement
college graduates

Cornerstone University’s SOAR program offers accredited bachelor’s and master’s degrees in business, Moreno-Riaño said. (iStock)

“In the app, there will be mini-lectures, podcasts, book reviews, interviews, all with very closely, carefully designed learning objectives throughout the program,” Moreno-Riaño said, explaining that some of the lectures may be in the range of 5 to 10 minutes. 

“We have micro assessments built-in that are immediately graded and feedback is given to the student.”

Some of the program’s first graduates told Moreno-Riaño that they listen to some of the lessons while commuting to work, while traveling or doing household chores.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Advertisement

“It allows them to, in essence, continue the learning experience amidst a complex schedule because we unbundle it, unpackage it, redevelop it and maintain the engagement criteria so that students stay studying and focused,” he said.

Continue Reading

Business

Mondelez CEO highlights innovation agenda

Published

on

Mondelez CEO highlights innovation agenda

New offerings key as “basket not going up” for consumers.

Continue Reading

Trending

Copyright © 2025